Attention: This platform is in beta mode. Expect some changes and adjustments.

AI Market Mood: Stock Dashboard

NSC


Fundamental

Company: Norfolk Southern Corp
Sector: Industrials
Industry: Railroads
Country: USA
Exchange: NYSE
Index: S&P 500
P/E: 21.68
EPS (ttm): 13.11
Insider Own: 0.06%
Shs Outstand: 244.71M
Perf Week: 0.31%
Market Cap: 69.56B
Forward P/E: 21.48
EPS next Y: 13.23
Insider Trans: 2.98%
Shs Float: 244.55M
Perf Month: -3.61%
Enterprise Value: 85.22B
PEG: 2.82
EPS next Q: 2.92
Inst Own: 74.44%
Short Float: 2.59%
Perf Quarter: 2.13%
Income: 2.96B
P/S: 5.69
EPS this Y: 3.03%
Inst Trans: 0.26%
Short Ratio: 3.93
Perf Half Y: 27.18%
Sales: 12.23B
P/B: 4.21
EPS next Y Percentage: 8.38%
ROA: 6.74%
Short Interest: 6.33M
Perf YTD: 21.11%
Book/sh: 67.48
P/C: 49.05
EPS next 5Y: 7.70%
ROE: 20.46%
52W High: 302.24 -5.95%
Perf Year: 12.75%
Cash/sh: 5.79
P/FCF: 33.14
EPS past 3/5Y: -1.51% 2.46%
ROIC: 9.36%
52W Low: 201.63 40.98%
Perf 3Y: 26.11%
Dividend Est.: 5.41 (1.90%)
EV/EBITDA: 15.37
Sales past 3/5Y: 2.85% 1.42%
Gross Margin: 34.05%
Volatility W: 1.18%
Volatility M: 1.44%
Perf 5Y: 32.17%
Dividend TTM: 5.40 (1.90%)
EV/Sales: 6.97
EPS Y/Y TTM: 22.88%
Oper. Margin: 34.05%
ATR (14): 3.96
Perf 10Y: 255.18%
Dividend Ex-Date: Nov 07, 2025
Quick Ratio: 0.78
Sales Y/Y TTM: 0.48%
Profit Margin: 24.19%
RSI (14): 47.83
Recom: 2.43
Dividend Gr. 3/5Y: 9.09% 8.45%
Current Ratio: 0.86
EPS Q/Q: -34.88%
SMA20: -0.29%
Beta: 1.31
Target Price: 313.47
Payout: 46.66%
Debt/Eq: 1.13
Sales Q/Q: 1.70%
SMA50: -0.65%
Rel Volume: 0.68
Prev Close: 282.10
Employees: 19600
LT Debt/Eq: 1.09
Earnings: Oct 23 AMC
SMA200: 9.94%
Avg Volume: 1.61M
Price: 284.25
IPO: Jun 02, 1982
Option/Short: Yes / Yes
EPS/Sales Surpr.: 3.47% -0.38%
Trades:
Volume: 1,090,369
Change: 0.76%

Technical:


Latest News:

Cisco Systems (CSCO) Q2 2025 Earnings Call Transcript | The Motley Fool somewhat bullish
CSCO

Summary: Cisco Systems (CSCO) reported strong demand growth in various portfolios, especially in Nexus portfolio and data center switching, indicating ongoing customer spending on technology despite geopolitical risks and market uncertainty. The company highlighted the excitement and fear among customers regarding technological advancements and competition. Major focus was on AI preparation and the introduction of innovative products like the 9,300 Nexus switch with AMD DPU for enhanced security integration into the network.

Full article
2025-02-13T05:06:15Z
Kraft Heinz (KHC) Q4 2024 Earnings Call Transcript | The Motley Fool neutral
KHC

Summary: Kraft Heinz (KHC) reported Q4 2024 earnings call where they highlighted achievements in 2024, focused on returning value to stockholders, and outlined strategies for 2025 to improve top-line growth while maintaining profitability. They addressed questions on disciplined reinvestment, growth pillars, tax rate impacts, Lunchables recovery, marketing spending, and initiatives to drive organic sales growth. Management emphasized leveraging their Brand Growth System for specific brand improvements and strategies tailored to different product categories.

Full article
2025-02-12T18:34:02Z
CVS Health (CVS) Q4 2024 Earnings Call Transcript | The Motley Fool neutral
CVS

Summary: CVS Health reported fourth quarter results with adjusted earnings per share of $1.19 and provided initial full year 2025 guidance. The company expects meaningful recovery in the Aetna business, continued growth in Health Services, and adjusted EPS in the range of $5.75 to $6 for 2025. The management expressed confidence in realizing the promise of CVS Health and discussed priorities to deliver results and create shareholder value.

Full article
2025-02-12T18:24:43Z
FedEx (FDX) Q1 2025 Earnings Call Transcript - The Motley Fool somewhat bearish
FDX

Summary: FDX reported a challenging Q1 with weaker-than-expected demand environment. Actions are being taken to focus on structural cost reduction through DRIVE and executing network transformation plans. Confidence remains in value-creation opportunities ahead.

Full article
2024-09-20T03:03:17Z
Merck & Co., Inc. (MRK) Bank of America Global Healthcare Conference (Transcript) somewhat bullish
MRK

Summary: Merck & Co., Inc. provides an update on their strong performance and pipeline progress during the Bank of America Global Healthcare Conference. They have shown growth in the second quarter and raised their full-year guidance.

Full article
2024-09-18T17:34:46Z
Bristol-Myers Squibb Company (BMY) Wells Fargo 2024 Healthcare Conference (Transcript) somewhat bullish
BMY

Summary: Bristol-Myers Squibb (NYSE:BMY) Chief Commercialization Officer discussed the company's strong Q2 performance, growth portfolio momentum, upcoming product launches like KarXT, and a positive outlook for long-term sustainable growth. The company is optimistic about various data readouts and expects continued growth in key products like Breyanzi and Camzyos

Full article
2024-09-06T17:08:59Z
Intel Corporation (INTC) Citi Global Technology Conference - (Transcript) | Seeking Alpha neutral
INTC

Summary: Intel Corporation CFO, David Zinsner, discusses cost reduction plans, accelerated restructuring actions, benefits from the split into foundry and design business segments, progress on CPU manufacturing nodes, including 18A, expectations for material packaging revenue in the foundry business, positive developments in client and data center CPU markets, cautious outlook on the PC market despite potential upside drivers.

Full article
2024-09-06T16:46:59Z
Editas Medicine, Inc. (EDIT) Presents at Wells Fargo 2024 Healthcare Conference (Transcript) somewhat bullish
EDIT

Summary: Editas Medicine, Inc. (NASDAQ:EDIT) presented at the Wells Fargo 2024 Healthcare Conference on September 5, 2024, highlighting the progress on their CRISPR-based genome editing therapies for sickle cell disease and thalassemia. They are focused on autologous edited ex-vivo cell therapy, in-vivo editing therapeutic pipeline, and leveraging foundational IP. The company is optimistic about the prospects of the sickle cell market and differentiation from competitors like Vertex.

Full article
2024-09-06T15:19:49Z
Broadcom (AVGO) Q3 2024 Earnings Call Transcript | The Motley Fool somewhat bullish
AVGO

Summary: Broadcom (AVGO) reported strong fiscal Q3 2024 results with consolidated net revenue up 47% year on year. AI revenue continues to grow, VMware bookings accelerate, and non-AI semiconductor revenue has stabilized. Guidance for Q4 2024 includes semiconductor revenue of approximately $8 billion and infrastructure software revenue of about $6 billion, driving consolidated revenue to around $14 billion, up 51% year on year.

Full article
2024-09-06T01:26:52Z
Medtronic plc (NYSE:MDT) Q1 2025 Earnings Call Transcript - Insider Monkey somewhat bullish
MDT

Summary: Medtronic plc reported strong performance in their Q1 2025 earnings call, showcasing revenue growth of 5.3% and surpassing earning expectations. The company is confident about sustaining mid-single-digit revenue growth and increasing adjusted EPS, especially with the upcoming launches and advancements in various product segments.

Full article
2024-08-21T18:08:39Z
Target (TGT) Q2 2024 Earnings Call Transcript | The Motley Fool very bullish
TGT

Summary: Target Corporation (TGT) reported a strong second quarter performance with a 2% growth in comparable sales driven by traffic. The company's strategic focus on newness, value, and seasonal relevance contributed to the growth. Target Circle loyalty platform demonstrated progress with over 100 million members and saw 2 million new users in the second quarter. Digital services like Drive Up and Target Circle 360 experienced growth, with Drive Up exceeding $2 billion in sales. The company continues to invest in its team and technology to enhance guest experience.

Full article
2024-08-21T15:50:52Z
Q1 2025 Medtronic PLC Earnings Call Transcript - GuruFocus neutral
MDT

Summary: Medtronic PLC conducted their fiscal '25 first quarter earnings webcast with their executives providing comments on the results and outlook for the year.

Full article
2024-08-21T04:14:51Z